Notice: Draft Guideline for Prevention of Catheter-Associated Urinary 
Tract Infections 2008

Federal Register: June 3, 2009 (Volume 74, Number 105)
                  Page 26704

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (DHHS).

ACTION: Notice of document availability and request for public comment.

SUMMARY: This notice is a request for review of and comment on the 
Draft Guideline for Prevention of Catheter-Associated Urinary Tract 
Infections 2008, available on the following Web site: http://
wwwnd.cdc.gov/publiccomments/. This document is for use by infection 
prevention staff, healthcare epidemiologists, healthcare 
administrators, nurses, other healthcare providers, and persons 
responsible for developing, implementing, and evaluating infection 
prevention and control programs for healthcare settings across the 
continuum of care. The guideline updates and expands the 1981 Guideline 
for Prevention of Catheter-associated Urinary Tract Infections.

DATES: Comments must be received on or before July 6, 2009.

ADDRESSES: Comments on the Draft Guideline for Prevention of Catheter-
Associated Urinary Tract Infections should be submitted by e-mail to 
cauti@cdc.gov or by mail to CDC, Division of Healthcare Quality 
Promotion, Attn: Resource Center, 1600 Clifton Rd., NE., Mailstop A-31, 
Atlanta, Georgia 30333; or by fax 404-639-4049.

SUPPLEMENTARY INFORMATION: The Draft Guideline for Prevention of 
Catheter-Associated Urinary Tract Infections addresses prevention of 
CAUTI for patients in need of either short- or long-term urinary 
catheterization in any type of healthcare setting and includes data for 
indwelling urethral catheterization as well as alternative methods of 
urinary drainage. The guideline also includes specific recommendations 
for implementation, performance measurement, and surveillance. 
Recommendations for further research are also included to address the 
knowledge gaps in CAUTI prevention identified during the literature 
review. The guideline is based on a targeted systematic review of the 
best available evidence with explicit links between the evidence and 
recommendations.

    Dated: May 21, 2009.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-12901 Filed 6-2-09; 8:45 am]

BILLING CODE 4163-18-P